A permanently charged tamoxifen derivative displays anticancer activity and improved tissue selectivity in rodents

Anat Biegon*, Marcus Brewster, Hadassa Degani, Emil Pop, Dalia Somjen, Alvin M. Kaye

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

A quaternized form of tamoxifen (TAM), tamoxifen methiodide (TMI), was shown to demonstrate very low brain uptake compared to TAM and, unexpectedly, was considerably less estrogenic than TAM in the uterus. The agonist activity of TMI in the bone was similar to that of TAM. TMI manifested significant dose-dependent tumoricidal activity with a rapid onset of action against MCF- 7 human breast cancer implants in nude mice and a mean reduction in tumor size of 60% over six weeks.

Original languageEnglish
Pages (from-to)4328-4331
Number of pages4
JournalCancer Research
Volume56
Issue number19
StatePublished - 1 Oct 1996
Externally publishedYes

Fingerprint

Dive into the research topics of 'A permanently charged tamoxifen derivative displays anticancer activity and improved tissue selectivity in rodents'. Together they form a unique fingerprint.

Cite this